Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface

IgM molecules circulate in serum as large polymers, mainly pentamers, which can be transported by the poly‐Ig receptor (pIgR) across epithelial cells to mucosal surfaces and released as secretory IgM (SIgM). The mucosal SIgM molecules have non‐covalently attached secretory component (SC), which is t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of immunology 2017-01, Vol.85 (1), p.43-50
Hauptverfasser: Michaelsen, T. E., Emilsen, S., Sandin, R. H., Granerud, B. K., Bratlie, D., Ihle, O., Sandlie, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:IgM molecules circulate in serum as large polymers, mainly pentamers, which can be transported by the poly‐Ig receptor (pIgR) across epithelial cells to mucosal surfaces and released as secretory IgM (SIgM). The mucosal SIgM molecules have non‐covalently attached secretory component (SC), which is the extracellular part of pIgR which is cleaved from the epithelial cell membrane. Serum IgM antibodies do not contain SC and have previously been shown to make a conformational change from ‘a star’ to a ‘staple’ conformation upon reaction with antigens on a cell surface, enabling them to activate complement. However, it is not clear whether SIgM similarly can induce complement activation. To clarify this issue, we constructed recombinant chimeric (mouse/human) IgM antibodies against hapten 5‐iodo‐4‐hydroxy‐3‐nitro‐phenacetyl (NIP) and in addition studied polyclonal IgM formed after immunization with a meningococcal group B vaccine. The monoclonal and polyclonal IgM molecules were purified by affinity chromatography on a column containing human SC in order to isolate joining‐chain (J‐chain) containing IgM, followed by addition of excess amounts of soluble SC to create SIgM (IgM J+ SC+). These SIgM preparations were tested for complement activation ability and shown to be nearly as active as the parental IgM J+ molecules. Thus, SIgM may offer protection against pathogens at mucosal surface by complement‐mediated cell lysis or by phagocytosis mediated by complement receptors present on effector cells on mucosa.
ISSN:0300-9475
1365-3083
DOI:10.1111/sji.12508